JP2018502877A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018502877A5 JP2018502877A5 JP2017538327A JP2017538327A JP2018502877A5 JP 2018502877 A5 JP2018502877 A5 JP 2018502877A5 JP 2017538327 A JP2017538327 A JP 2017538327A JP 2017538327 A JP2017538327 A JP 2017538327A JP 2018502877 A5 JP2018502877 A5 JP 2018502877A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- haloalkyl
- amino
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 86
- 125000001188 haloalkyl group Chemical group 0.000 claims 69
- 229910052736 halogen Inorganic materials 0.000 claims 68
- 150000002367 halogens Chemical class 0.000 claims 61
- 125000004663 dialkyl amino group Chemical group 0.000 claims 60
- 125000003282 alkyl amino group Chemical group 0.000 claims 56
- -1 cyano, hydroxy Chemical group 0.000 claims 56
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 53
- 125000004103 aminoalkyl group Chemical group 0.000 claims 51
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 50
- 125000003545 alkoxy group Chemical group 0.000 claims 49
- 125000004438 haloalkoxy group Chemical group 0.000 claims 48
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 36
- 125000003118 aryl group Chemical group 0.000 claims 30
- 125000001072 heteroaryl group Chemical group 0.000 claims 26
- 125000001424 substituent group Chemical group 0.000 claims 25
- 125000004414 alkyl thio group Chemical group 0.000 claims 24
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 23
- 125000004440 haloalkylsulfinyl group Chemical group 0.000 claims 23
- 125000000623 heterocyclic group Chemical group 0.000 claims 23
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 22
- 150000001875 compounds Chemical class 0.000 claims 22
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 claims 22
- 125000002950 monocyclic group Chemical group 0.000 claims 21
- 125000003342 alkenyl group Chemical group 0.000 claims 20
- 125000004995 haloalkylthio group Chemical group 0.000 claims 19
- 125000004043 oxo group Chemical group O=* 0.000 claims 18
- 125000000304 alkynyl group Chemical group 0.000 claims 17
- 125000000232 haloalkynyl group Chemical group 0.000 claims 17
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 17
- 125000002993 cycloalkylene group Chemical group 0.000 claims 16
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 14
- 125000000753 cycloalkyl group Chemical group 0.000 claims 14
- 125000000262 haloalkenyl group Chemical group 0.000 claims 14
- 125000005843 halogen group Chemical group 0.000 claims 14
- 125000003277 amino group Chemical group 0.000 claims 10
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 8
- 125000005140 aralkylsulfonyl group Chemical group 0.000 claims 8
- 125000004659 aryl alkyl thio group Chemical group 0.000 claims 8
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 8
- 125000005135 aryl sulfinyl group Chemical group 0.000 claims 8
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 8
- 125000005110 aryl thio group Chemical group 0.000 claims 8
- 125000004104 aryloxy group Chemical group 0.000 claims 8
- 125000005367 heteroarylalkylthio group Chemical group 0.000 claims 8
- 125000005150 heteroarylsulfinyl group Chemical group 0.000 claims 8
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 claims 8
- 125000002877 alkyl aryl group Chemical group 0.000 claims 7
- 125000005842 heteroatom Chemical group 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 4
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims 4
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 4
- 125000005368 heteroarylthio group Chemical group 0.000 claims 4
- 125000002619 bicyclic group Chemical group 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 claims 2
- 206010061217 Infestation Diseases 0.000 claims 2
- 150000008282 halocarbons Chemical group 0.000 claims 2
- YNADRQHQKCKSCL-UHFFFAOYSA-N morpholine-2,4-diyl Chemical group C1C[O+]=CC[N-]1 YNADRQHQKCKSCL-UHFFFAOYSA-N 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 208000026803 Animal Parasitic disease Diseases 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 208000030852 Parasitic disease Diseases 0.000 claims 1
- 238000010276 construction Methods 0.000 claims 1
- 125000004956 cyclohexylene group Chemical group 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000000590 parasiticidal effect Effects 0.000 claims 1
- 239000002297 parasiticide Substances 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562105463P | 2015-01-20 | 2015-01-20 | |
| US62/105,463 | 2015-01-20 | ||
| PCT/US2016/014148 WO2016118638A1 (en) | 2015-01-20 | 2016-01-20 | Anthelmintic compounds, compositions and method of using thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018502877A JP2018502877A (ja) | 2018-02-01 |
| JP2018502877A5 true JP2018502877A5 (enExample) | 2019-02-21 |
| JP6771469B2 JP6771469B2 (ja) | 2020-10-21 |
Family
ID=55299781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017538327A Expired - Fee Related JP6771469B2 (ja) | 2015-01-20 | 2016-01-20 | 駆虫性化合物、組成物及びこれらの使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10597364B2 (enExample) |
| EP (1) | EP3247701B1 (enExample) |
| JP (1) | JP6771469B2 (enExample) |
| CN (1) | CN107257793A (enExample) |
| AU (3) | AU2016209321B2 (enExample) |
| BR (1) | BR112017015273A2 (enExample) |
| CA (1) | CA2973873A1 (enExample) |
| ES (1) | ES2907461T3 (enExample) |
| MX (1) | MX379304B (enExample) |
| NZ (1) | NZ734082A (enExample) |
| WO (1) | WO2016118638A1 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2545964A1 (en) | 2011-07-13 | 2013-01-16 | Phenex Pharmaceuticals AG | Novel FXR (NR1H4) binding and activity modulating compounds |
| CA2968836C (en) | 2016-06-13 | 2025-09-02 | Gilead Sciences, Inc. | FXR MODULATING COMPOUNDS (NR1H4) |
| NZ748641A (en) | 2016-06-13 | 2020-04-24 | Gilead Sciences Inc | Fxr (nr1h4) modulating compounds |
| KR102359707B1 (ko) | 2016-07-20 | 2022-02-09 | 노파르티스 아게 | 아미노피리딘 유도체 및 이의 선택적 alk-2 억제제로서의 용도 |
| ES2982801T3 (es) | 2017-03-28 | 2024-10-17 | Gilead Sciences Inc | Combinaciones terapéuticas para el tratamiento de las enfermedades hepáticas |
| MX2020001425A (es) | 2017-08-04 | 2020-08-06 | Skyhawk Therapeutics Inc | Metodos y composiciones para modular el empalme. |
| TWI793151B (zh) | 2017-08-23 | 2023-02-21 | 瑞士商諾華公司 | 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途 |
| AR116109A1 (es) | 2018-07-10 | 2021-03-31 | Novartis Ag | Derivados de 3-(5-amino-1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos |
| BR122022012697B1 (pt) | 2018-07-10 | 2023-04-04 | Novartis Ag | Usos de derivados de 3-(5-hidróxi-1-oxoisoindolin-2-il)piperidina-2,6- diona, e kit |
| AR116524A1 (es) * | 2018-10-04 | 2021-05-19 | Elanco Tiergesundheit Ag | Potenciación de tratamiento de helmintos |
| TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
| GB201820626D0 (en) * | 2018-12-18 | 2019-01-30 | Univ Of Canterbury | Conjugates |
| KR102692309B1 (ko) | 2019-01-15 | 2024-08-07 | 길리애드 사이언시즈, 인코포레이티드 | Fxr (nr1h4) 조정 화합물 |
| WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
| BR112021013924A2 (pt) | 2019-01-18 | 2021-09-21 | Astrazeneca Ab | Inibidores de pcsk9 e métodos de uso do mesmo |
| WO2020163248A1 (en) | 2019-02-04 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| WO2020163541A1 (en) | 2019-02-05 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| KR102913697B1 (ko) | 2019-02-05 | 2026-01-15 | 스카이호크 테라퓨틱스, 인코포레이티드 | 스플라이싱을 조절하는 방법 및 조성물 |
| JP7603594B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| KR102925385B1 (ko) | 2019-02-06 | 2026-02-11 | 스카이호크 테라퓨틱스, 인코포레이티드 | 스플라이싱을 조절하는 방법 및 조성물 |
| WO2020172075A1 (en) | 2019-02-19 | 2020-08-27 | Gilead Sciences, Inc. | Solid forms of fxr agonists |
| KR20220002890A (ko) * | 2019-03-19 | 2022-01-07 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | 구충성 아자-벤조티오펜 및 아자-벤조푸란 화합물 |
| AR119731A1 (es) | 2019-05-17 | 2022-01-05 | Novartis Ag | Inhibidores del inflamasoma nlrp3 |
| US11129829B2 (en) | 2019-06-17 | 2021-09-28 | Skyhawk Therapeutics, Inc. | Methods for modulating splicing |
| CR20220178A (es) | 2019-10-25 | 2022-06-15 | Gilead Sciences Inc | Compuestos moduladores de glp-1r |
| TW202131926A (zh) | 2019-11-22 | 2021-09-01 | 美商英塞特公司 | 包含alk2抑制劑及jak2抑制劑的組合療法 |
| SI4097097T1 (sl) | 2020-01-29 | 2025-04-30 | Gilead Sciences, Inc. | Spojine, ki modulirajo glp-1r |
| KR20230051425A (ko) | 2020-04-07 | 2023-04-18 | 미토브리지, 인크. | Cd38 억제제 |
| IL298219A (en) | 2020-05-15 | 2023-01-01 | Algen Biotechnologies Inc | Certain chemical compositions and methods of use thereof |
| IL298767A (en) | 2020-06-16 | 2023-02-01 | Incyte Corp | ALK2 inhibitors for the treatment of anemia |
| EP4247804A1 (en) | 2020-11-20 | 2023-09-27 | Gilead Sciences, Inc. | Polyheterocyclic glp-1 r modulating compounds |
| US12180197B2 (en) | 2021-03-11 | 2024-12-31 | Gilead Sciences, Inc. | GLP-1R modulating compounds |
| EP4304711A1 (en) | 2021-03-11 | 2024-01-17 | Gilead Sciences, Inc. | Glp-1r modulating compounds |
| US11932630B2 (en) | 2021-04-16 | 2024-03-19 | Novartis Ag | Heteroaryl aminopropanol derivatives |
| LT4271672T (lt) | 2021-04-21 | 2026-03-10 | Gilead Sciences, Inc. | Karboksibenzimidazolo junginiai, moduliuojantys glp-1r |
| UY40374A (es) | 2022-08-03 | 2024-02-15 | Novartis Ag | Inhibidores de inflamasoma nlrp3 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4208254A1 (de) | 1992-03-14 | 1993-09-16 | Hoechst Ag | Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid |
| AU1631699A (en) | 1997-12-18 | 1999-07-05 | E.I. Du Pont De Nemours And Company | Cyclohexylamine arthropodicides and fungicides |
| AU2001233044A1 (en) | 2000-01-28 | 2001-08-07 | Akkadix Corporation | Methods for killing nematodes and nematode eggs using bis-amino-1,2,4-thiadiazoles |
| EP1403255A4 (en) * | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | RHO KINASE INHIBITORS |
| EP1689722A2 (en) * | 2003-10-10 | 2006-08-16 | Bayer Pharmaceuticals Corporation | 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| EP1751136B1 (en) * | 2004-05-07 | 2014-07-02 | Amgen Inc. | Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
| DE102005032838A1 (de) * | 2005-07-14 | 2007-02-08 | Merck Patent Gmbh | Mischung von Onium-Alkylsulfonaten und Onium-Alkylsulfiten |
| WO2007063839A1 (ja) * | 2005-11-30 | 2007-06-07 | Shionogi & Co., Ltd. | シクロヘキサン誘導体 |
| TW200938203A (en) | 2007-12-17 | 2009-09-16 | Intervet Int Bv | Anthelmintic agents and their use |
| TW201041868A (en) * | 2009-03-20 | 2010-12-01 | Intervet Int Bv | Anthelmintic agents and their use |
| TW201111358A (en) | 2009-06-18 | 2011-04-01 | Intervet Int Bv | Anthelmintic agents and their use |
| CA2774573A1 (en) * | 2009-10-09 | 2011-04-14 | Irm Llc | Compounds and compositions as modulators of gpr119 activity |
| US8952037B2 (en) * | 2010-05-13 | 2015-02-10 | Amgen Inc. | Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors |
| EP2569302A1 (en) * | 2010-05-13 | 2013-03-20 | Amgen, Inc | Heteroaryloxyheterocyclyl compounds as pde10 inhibitors |
| EP2468096A1 (en) | 2010-12-21 | 2012-06-27 | Intervet International BV | Anthelmintic combinations |
| US8530461B2 (en) * | 2011-12-29 | 2013-09-10 | Boehringer Ingelheim International Gmbh | Azetidine derivatives |
| WO2014023723A1 (en) | 2012-08-08 | 2014-02-13 | Novartis Ag | Subtituted azines as pesticides |
| NZ716598A (en) * | 2012-11-20 | 2017-02-24 | Merial Inc | Anthelmintic compounds and compositions and method of using thereof |
| RS62649B1 (sr) | 2013-03-12 | 2021-12-31 | Vertex Pharma | Inhibitori dnk-pk |
| ES2659023T3 (es) | 2013-11-18 | 2018-03-13 | Elanco Tiergesundheit Ag | (Hetero)arilamidas para el control de endoparásitos |
| NZ726874A (en) | 2014-05-19 | 2018-03-23 | Merial Inc | Anthelmintic compounds |
-
2016
- 2016-01-20 ES ES16702865T patent/ES2907461T3/es active Active
- 2016-01-20 JP JP2017538327A patent/JP6771469B2/ja not_active Expired - Fee Related
- 2016-01-20 CA CA2973873A patent/CA2973873A1/en not_active Abandoned
- 2016-01-20 EP EP16702865.3A patent/EP3247701B1/en active Active
- 2016-01-20 MX MX2017009408A patent/MX379304B/es unknown
- 2016-01-20 US US15/544,837 patent/US10597364B2/en active Active
- 2016-01-20 NZ NZ734082A patent/NZ734082A/en not_active IP Right Cessation
- 2016-01-20 WO PCT/US2016/014148 patent/WO2016118638A1/en not_active Ceased
- 2016-01-20 CN CN201680010899.2A patent/CN107257793A/zh active Pending
- 2016-01-20 AU AU2016209321A patent/AU2016209321B2/en not_active Ceased
- 2016-01-20 BR BR112017015273-8A patent/BR112017015273A2/pt active Search and Examination
-
2019
- 2019-04-18 AU AU2019202773A patent/AU2019202773B2/en not_active Ceased
-
2020
- 2020-06-30 AU AU2020204400A patent/AU2020204400A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2007134380A (ru) | Антибактериальные производные пиперидина | |
| RU2460730C2 (ru) | Новые производные n-(8-гетероарилтетрагидронафталин-2-ил)-или n-(5-гетероарилхроман-3-ил)-карбоксамида для лечения боли | |
| RU2401658C2 (ru) | Гетероциклические ингибиторы аспартилпротеазы | |
| RU2011121567A (ru) | Изоиндолиновые соединения для применения при лечении рака | |
| JP2016506962A5 (enExample) | ||
| JP2018524390A5 (enExample) | ||
| CA2634676A1 (en) | Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein cetp | |
| JP2014514360A5 (enExample) | ||
| NZ612041A (en) | Compounds and their use as bace inhibitors | |
| RU2018106453A (ru) | Соединения | |
| JP2010525056A5 (enExample) | ||
| RU2017118165A (ru) | Ингибиторы энхансера гомолога 2 zestes | |
| JP2020516591A (ja) | Ｍｏｒアゴニストおよびｋｏｒアゴニストを含有する医薬組成物、およびその用途 | |
| RU2017116196A (ru) | 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 | |
| RU2009144538A (ru) | Новые циклические пептидные соединения | |
| PE20161369A1 (es) | Inhibidores de monoacilglicerol aciltransferasa 2 (mgat2) de dihidropiridinona sustituidos con tetrazolona | |
| MX350418B (es) | Inhibidores de bifluorodioxalano-amino-bencimidazol quinasa para el tratamiento de cáncer, inflamación autoinmune y trastornos del sistema nervioso central. | |
| RU2006130000A (ru) | Органические соединения | |
| RU2007130144A (ru) | Гетероциклические соединения в качестве антагонистов cccr2b | |
| RU2016142611A (ru) | Пролекарственные средства ингибиторов обратной транскриптазы вич | |
| BR112015016184A2 (pt) | derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral | |
| JP2020503293A5 (enExample) | ||
| JP2009537606A5 (enExample) | ||
| RU2015149956A (ru) | Новые соединения 3,4-дигидро-2н-изохинолин-1-она и 2,3-дигидроизоиндол-1-она | |
| JP2013515031A5 (enExample) |